| Product Code: ETC9514167 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import of interferons in 2024 saw a significant increase in concentration, with top exporting countries being Peru, Netherlands, USA, Brazil, and Germany. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, which intensified in 2024. Despite a modest compound annual growth rate (CAGR) of 2.08% from 2020 to 2024, there was a notable decline in growth rate (-8.75%) from 2023 to 2024. This suggests a shifting landscape in the interferons market in Suriname, potentially influenced by various factors impacting import trends.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Interferons Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Interferons Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Interferons Market - Industry Life Cycle |
3.4 Suriname Interferons Market - Porter's Five Forces |
3.5 Suriname Interferons Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Interferons Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Suriname Interferons Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Suriname Interferons Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Suriname Interferons Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Interferons Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases that can be treated with interferons in Suriname |
4.2.2 Growing awareness and adoption of advanced medical treatments in the country |
4.2.3 Government initiatives to improve healthcare infrastructure and access to innovative therapies |
4.3 Market Restraints |
4.3.1 High cost of interferon therapy leading to affordability issues for patients |
4.3.2 Limited availability and accessibility of specialized healthcare facilities in Suriname |
4.3.3 Stringent regulatory requirements for approval and use of interferon treatments in the market |
5 Suriname Interferons Market Trends |
6 Suriname Interferons Market, By Types |
6.1 Suriname Interferons Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Interferons Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Interferons Market Revenues & Volume, By Alpha, 2021- 2031F |
6.1.4 Suriname Interferons Market Revenues & Volume, By Beta, 2021- 2031F |
6.1.5 Suriname Interferons Market Revenues & Volume, By Gamma, 2021- 2031F |
6.1.6 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Interferons Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Suriname Interferons Market Revenues & Volume, By Chronic Hepatitis, 2021- 2031F |
6.2.3 Suriname Interferons Market Revenues & Volume, By Leukemia, 2021- 2031F |
6.2.4 Suriname Interferons Market Revenues & Volume, By AIDS, 2021- 2031F |
6.2.5 Suriname Interferons Market Revenues & Volume, By Kaposi Sarcoma, 2021- 2031F |
6.2.6 Suriname Interferons Market Revenues & Volume, By Malignant Melanoma, 2021- 2031F |
6.2.7 Suriname Interferons Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.8 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Interferons Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Suriname Interferons Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.3 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Suriname Interferons Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Suriname Interferons Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Suriname Interferons Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Suriname Interferons Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Suriname Interferons Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Suriname Interferons Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Suriname Interferons Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Suriname Interferons Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Suriname Interferons Market Import-Export Trade Statistics |
7.1 Suriname Interferons Market Export to Major Countries |
7.2 Suriname Interferons Market Imports from Major Countries |
8 Suriname Interferons Market Key Performance Indicators |
8.1 Patient adherence rate to interferon therapy |
8.2 Number of healthcare facilities offering interferon treatments in Suriname |
8.3 Rate of government funding allocated to healthcare infrastructure development in the country |
9 Suriname Interferons Market - Opportunity Assessment |
9.1 Suriname Interferons Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Interferons Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Suriname Interferons Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Suriname Interferons Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Suriname Interferons Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Interferons Market - Competitive Landscape |
10.1 Suriname Interferons Market Revenue Share, By Companies, 2024 |
10.2 Suriname Interferons Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |